Sarcopenia - Pipeline Insights, 2018 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Sep 14, 2018--The “Sarcopenia-Pipeline Insights, 2018” drug pipelines has been added to ResearchAndMarkets.com’s offering.
This report offers a comprehensive insight of the pipeline (under development) therapeutics scenario and growth prospects across Sarcopenia development.
The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.
ScopeThe report provides a snapshot of the pipeline development for Sarcopenia The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for Sarcopenia The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Sarcopenia The report also covers the dormant and discontinued pipeline projects related to Sarcopenia
Companies FeaturedDainippon Sumitomo Pharma Co., Ltd. GTX, Inc. MYOS Corporation Regeneron Pharmaceuticals Eli Lilly and Company Endo Pharmaceuticals Novartis AG Biophytis ARMGO Pharma Celgene Cellular Therapeutics
Key Topics Covered
1. Report Introduction
2. Sarcopenia Overview
3. Pipeline TherapeuticsAn Overview of Pipeline Products for Sarcopenia
4. Comparative Analysis
5. Products in Clinical Stage 5.1 Drug Name: Company NameProduct Description Research and Development Product Development Activities
6. Products in Pre-Clinical and Discovery Stage 6.1 Drug Name: Company NameProduct Description Research and Development Product Development Activities
7. Therapeutic AssessmentAssessment by Route of Administration Assessment by Stage and Route of Administration Assessment by Molecule Type Assessment by Stage and Molecule Type
8. Inactive Products 8.1 Drug Name: Company NameProduct Description Research and Development Product Development Activities
For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/gstvbt/sarcopenia?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180914005311/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Musculoskeletal Disorders Drugs,Drugs by Therapeutic Area
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 09/14/2018 09:52 AM/DISC: 09/14/2018 09:52 AM